Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2019

Nov 13, 2019

SELL
$13.89 - $23.16 $5.05 Million - $8.42 Million
-363,600 Closed
0 $0
Q2 2019

Aug 13, 2019

BUY
$16.27 - $20.51 $1.08 Million - $1.36 Million
66,100 Added 22.22%
363,600 $7.05 Million
Q1 2019

May 08, 2019

BUY
$12.61 - $22.33 $3.75 Million - $6.64 Million
297,500 New
297,500 $6.18 Million

Others Institutions Holding AMRN

About AMARIN CORP PLCUK


  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $258M
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track Laurion Capital Management LP Portfolio

Follow Laurion Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Laurion Capital Management LP with notifications on news.